The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
The Impact of Vaccination on Coronavirus Disease 2019 (COVID-19) Outbreaks in the United States
Open accessAbstract
Background: Global vaccine development efforts have been accelerated in response to the devastating coronavirus disease 2019 (COVID-19) pandemic. We evaluated the impact of a 2-dose COVID-19 vaccination campaign on reducing incidence, hospitalizations, and deaths in the United States. Methods: We developed an agent-based model of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) transmission and parameterized it with US demographics and age-specific COVID-19 outcomes. Healthcare workers and high-risk individuals were prioritized for vaccination, whereas children under 18 years of age were not vaccinated. We considered a vaccine efficacy of 95% against disease following 2 doses administered 21 days apart achieving 40% vaccine coverage of the overall population within 284 days. We varied vaccine efficacy against infection and specified 10% preexisting population immunity for the base-case scenario. The model was calibrated to an effective reproduction number of 1.2, accounting for current nonpharmaceutical interventions in the United States. Results: Vaccination reduced the overall attack rate to 4.6% (95% credible interval [CrI]: 4.3%–5.0%) from 9.0% (95% CrI: 8.4%–9.4%) without vaccination, over 300 days. The highest relative reduction (54%–62%) was observed among individuals aged 65 and older. Vaccination markedly reduced adverse outcomes, with non-intensive care unit (ICU) hospitalizations, ICU hospitalizations, and deaths decreasing by 63.5% (95% CrI: 60.3%–66.7%), 65.6% (95% CrI: 62.2%–68.6%), and 69.3% (95% CrI: 65.5%–73.1%), respectively, across the same period. Conclusions: Our results indicate that vaccination can have a substantial impact on mitigating COVID-19 outbreaks, even with limited protection against infection. However, continued compliance with nonpharmaceutical interventions is essential to achieve this impact.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia
Li, Q., Guan, X., Wu, P., Wang, X., Zhou, L., Tong, Y., Ren, R., Leung, K. S. M., Lau, E. H. Y., Wong, J. Y., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2001316 · Cited by 16,575
Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine
Polack, F. P., Thomas, S. J., Kitchin, N., Absalon, J., Gurtman, A., Lockhart, S., Perez, J. L., Pérez Marc, G., Moreira, E. D., Zerbini, C., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2034577 · Cited by 14,592
Yang, X., Yu, Y., Xu, J., Shu, H., Xia, J., Liu, H., Wu, Y., Zhang, L., Yu, Z., Fang, M., et al. (2020) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(20)30079-5 · Cited by 10,066
Voysey, M., Clemens, S. A. C., Madhi, S. A., Weckx, L. Y., Folegatti, P. M., Aley, P. K., Angus, B., Baillie, V. L., Barnabas, S. L., Bhorat, Q. E., et al. (2021) · The Lancet · doi:10.1016/s0140-6736(20)32661-1 · Cited by 4,616
Temporal dynamics in viral shedding and transmissibility of COVID-19
He, X., Lau, E. H. Y., Wu, P., Deng, X., Wang, J., Hao, X., Lau, Y. C., Wong, J. Y., Guan, Y., Tan, X., et al. (2020) · Nature Medicine · doi:10.1038/s41591-020-0869-5 · Cited by 4,247
Yang, J., Zheng, Y., Gou, X., Pu, K., Chen, Z., Guo, Q., Ji, R., Wang, H., Wang, Y., & Zhou, Y. (2020) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2020.03.017 · Cited by 4,206
Li, R., Pei, S., Chen, B., Song, Y., Zhang, T., Yang, W., & Shaman, J. (2020) · Science · doi:10.1126/science.abb3221 · Cited by 3,633
Estimating the effects of non-pharmaceutical interventions on COVID-19 in Europe
Flaxman, S., Mishra, S., Gandy, A., Unwin, H. J. T., Mellan, T. A., Coupland, H., Whittaker, C., Zhu, H., Berah, T., Eaton, J. W., et al. (2020) · Nature · doi:10.1038/s41586-020-2405-7 · Cited by 3,350
Social Contacts and Mixing Patterns Relevant to the Spread of Infectious Diseases
Mossong, J., Hens, N., Jit, M., Beutels, P., Auranen, K., Mikolajczyk, R., Massari, M., Salmaso, S., Tomba, G. S., Wallinga, J., et al. (2008) · PLoS Medicine · doi:10.1371/journal.pmed.0050074 · Cited by 2,900
Quantifying SARS-CoV-2 transmission suggests epidemic control with digital contact tracing
Ferretti, L., Wymant, C., Kendall, M., Zhao, L., Nurtay, A., Abeler-Dörner, L., Parker, M., Bonsall, D., & Fraser, C. (2020) · Science · doi:10.1126/science.abb6936 · Cited by 2,512
Garg, S., Kim, L., Whitaker, M., O’Halloran, A., Cummings, C., Holstein, R., Prill, M., Chai, S. J., Kirley, P. D., Alden, N. B., et al. (2020) · MMWR. Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6915e3 · Cited by 2,335
Prevalence of Asymptomatic SARS-CoV-2 Infection: A Narrative Review
Oran, D. P., & Topol, E. J. (2020) · Annals of Internal Medicine · doi:10.7326/m20-3012 · Cited by 2,279
Mizumoto, K., Kagaya, K., Zarebski, A., & Chowell, G. (2020) · Eurosurveillance · doi:10.2807/1560-7917.es.2020.25.10.2000180 · Cited by 2,276
The COVID-19 vaccine development landscape
Thanh Le, T., Andreadakis, Z., Kumar, A., Gómez Román, R., Tollefsen, S., Saville, M., & Mayhew, S. (2020) · Nature Reviews Drug Discovery · doi:10.1038/d41573-020-00073-5 · Cited by 1,954
High Contagiousness and Rapid Spread of Severe Acute Respiratory Syndrome Coronavirus 2
Sanche, S., Lin, Y. T., Xu, C., Romero-Severson, E., Hengartner, N., & Ke, R. (2020) · Emerging Infectious Diseases · doi:10.3201/eid2607.200282 · Cited by 1,619
Coronavirus disease 2019 case surveillance—United States, January 22–May 30, 2020.
Stokes, E. K., Zambrano, L. D., Anderson, K. N., Marder, E. P., Raz, K. M., El Burai Felix, S., Tie, Y., & Fullerton, K. E. (2020) · MMWR Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6924e2 · Cited by 1,538 · cited 1×
“Moreover, severity of symptoms and risk of death increase precipitously with age [24, 25].”
Safety and Immunogenicity of SARS-CoV-2 mRNA-1273 Vaccine in Older Adults
Anderson, E. J., Rouphael, N. G., Widge, A. T., Jackson, L. A., Roberts, P. C., Makhene, M., Chappell, J. D., Denison, M. R., Stevens, L. J., Pruijssers, A. J., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2028436 · Cited by 1,523
Self-citationCDC COVID-19 Response Team, CDC COVID-19 Response Team, Chow, N., Fleming-Dutra, K., Gierke, R., Hall, A., Hughes, M., Pilishvili, T., Ritchey, M., Roguski, K., et al. (2020) · MMWR. Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6913e2 · Cited by 1,404
Does comorbidity increase the risk of patients with COVID-19: evidence from meta-analysis
Wang, B., Li, R., Lu, Z., & Huang, Y. (2020) · Aging · doi:10.18632/aging.103000 · Cited by 1,304
Estimation of the asymptomatic ratio of novel coronavirus infections (COVID-19)
Nishiura, H., Kobayashi, T., Miyama, T., Suzuki, A., Jung, S.-M., Hayashi, K., Kinoshita, R., Yang, Y., Yuan, B., Akhmetzhanov, A. R., et al. (2020) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2020.03.020 · Cited by 1,298
The positive impact of lockdown in Wuhan on containing the COVID-19 outbreak in China
Lau, H., Khosrawipour, V., Kocbach, P., Mikolajczyk, A., Schubert, J., Bania, J., & Khosrawipour, T. (2020) · Journal of Travel Medicine · doi:10.1093/jtm/taaa037 · Cited by 1,294
Spread and dynamics of the COVID-19 epidemic in Italy: Effects of emergency containment measures
Gatto, M., Bertuzzo, E., Mari, L., Miccoli, S., Carraro, L., Casagrandi, R., & Rinaldo, A. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2004978117 · Cited by 1,051
Kimball, A., Hatfield, K. M., Arons, M., James, A., Taylor, J., Spicer, K., Bardossy, A. C., Oakley, L. P., Tanwar, S., Chisty, Z., et al. (2020) · MMWR. Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6913e1 · Cited by 1,050
Rapid COVID-19 vaccine development
Graham, B. S. (2020) · Science · doi:10.1126/science.abb8923 · Cited by 771
Quantifying the impact of physical distance measures on the transmission of COVID-19 in the UK
CMMID COVID-19 working group, Jarvis, C. I., Van Zandvoort, K., Gimma, A., Prem, K., Klepac, P., Rubin, G. J., & Edmunds, W. J. (2020) · BMC Medicine · doi:10.1186/s12916-020-01597-8 · Cited by 720
Ageing and the epidemiology of multimorbidity
Divo, M. J., Martinez, C. H., & Mannino, D. M. (2014) · European Respiratory Journal · doi:10.1183/09031936.00059814 · Cited by 701
Kim, L., Garg, S., O’Halloran, A., Whitaker, M., Pham, H., Anderson, E. J., Armistead, I., Bennett, N. M., Billing, L., Como-Sabetti, K., et al. (2021) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa1012 · Cited by 649
Projecting hospital utilization during the COVID-19 outbreaks in the United States
Moghadas, S. M., Shoukat, A., Fitzpatrick, M. C., Wells, C. R., Sah, P., Pandey, A., Sachs, J. D., Wang, Z., Meyers, L. A., Singer, B. H., et al. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2004064117 · Cited by 494
Self-citationLancet, T. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30938-7 · Cited by 477
The implications of silent transmission for the control of COVID-19 outbreaks
Moghadas, S. M., Fitzpatrick, M. C., Sah, P., Pandey, A., Shoukat, A., Singer, B. H., & Galvani, A. P. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2008373117 · Cited by 449
Self-citationAnand, S., Montez-Rath, M., Han, J., Bozeman, J., Kerschmann, R., Beyer, P., Parsonnet, J., & Chertow, G. M. (2020) · The Lancet · doi:10.1016/s0140-6736(20)32009-2 · Cited by 265
Infectivity of asymptomatic versus symptomatic COVID-19
Sayampanathan, A. A., Heng, C. S., Pin, P. H., Pang, J., Leong, T. Y., & Lee, V. J. (2021) · The Lancet · doi:10.1016/s0140-6736(20)32651-9 · Cited by 180
Andrew, M. K., Shinde, V., Ye, L., Hatchette, T., Haguinet, F., Dos Santos, G., McElhaney, J. E., Ambrose, A., Boivin, G., Bowie, W., et al. (2017) · The Journal of Infectious Diseases · doi:10.1093/infdis/jix282 · Cited by 169
Self-citationProjecting demand for critical care beds during COVID-19 outbreaks in Canada
Shoukat, A., Wells, C. R., Langley, J. M., Singer, B. H., Galvani, A. P., & Moghadas, S. M. (2020) · Canadian Medical Association Journal · doi:10.1503/cmaj.200457 · Cited by 163
Self-citationNovel Coronavirus (COVID‐19) Epidemic: What Are the Risks for Older Patients?
Garnier‐Crussard, A., Forestier, E., Gilbert, T., & Krolak‐Salmon, P. (2020) · Journal of the American Geriatrics Society · doi:10.1111/jgs.16407 · Cited by 137
Dhakal, S., & Klein, S. L. (2019) · Journal of Virology · doi:10.1128/jvi.00797-19 · Cited by 129
Adams, M. L., Katz, D. L., & Grandpre, J. R. (2020) · Emerging infectious diseases · doi:10.3201/eid2608.200679 · Cited by 121
Failure in initial stage containment of global COVID‐19 epicenters
Khosrawipour, V., Lau, H., Khosrawipour, T., Kocbach, P., Ichii, H., Bania, J., & Mikołajczyk, A. (2020) · Journal of Medical Virology · doi:10.1002/jmv.25883 · Cited by 84
Just 50% of Americans plan to get a COVID-19 vaccine. Here’s how to win over the rest
Cornwall, W. (2020) · Science · doi:10.1126/science.abd6018 · Cited by 54
Cited by
Ebola Optimization Search Algorithm: A New Nature-Inspired Metaheuristic Optimization Algorithm
Oyelade, O. N., Ezugwu, A. E.-S., Mohamed, T. I. A., & Abualigah, L. (2022) · IEEE Access · doi:10.1109/access.2022.3147821 · Cited by 445
Evaluation of Waning of SARS-CoV-2 Vaccine–Induced Immunity: A Systematic Review and Meta-analysis
Menegale, F., Manica, M., Zardini, A., Guzzetta, G., Marziano, V., d'Andrea, V., Trentini, F., Ajelli, M., Poletti, P., & Merler, S. (2023) · JAMA Network Open · doi:10.1001/jamanetworkopen.2023.10650 · Cited by 280
Lee, B. E. C., Ling, M., Boyd, L., Olsson, C., & Sheen, J. (2023) · Journal of Affective Disorders · doi:10.1016/j.jad.2023.03.012 · Cited by 120
Characterizing the spatiotemporal heterogeneity of the COVID-19 vaccination landscape
Tiu, A., Susswein, Z., Merritt, A., & Bansal, S. (2021) · doi:10.1101/2021.10.04.21263345 · Cited by 37
Waning of SARS-CoV-2 vaccine-induced immunity: A systematic review and secondary data analysis
Menegale, F., Manica, M., Zardini, A., Guzzetta, G., Marziano, V., d’Andrea, V., Trentini, F., Ajelli, M., Poletti, P., & Merler, S. (2022) · doi:10.1101/2022.07.04.22277225 · Cited by 1
Metadata
- Authors
- Moghadas, S. M., Vilches, T. N., Zhang, K., Wells, C. R., Shoukat, A., Singer, B. H., Meyers, L. A., Neuzil, K. M., Langley, J. M., Fitzpatrick, M. C., & Galvani, A. P.
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2021-01-30
- Volume
- 73
- Issue
- 12
- Pages
- 2257-2264
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W3128361403
- Cited by
- 678
- References
- 39
- FWCI
- 56.70
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.